首页 >
法规速递
-
Page: ICH M15 guideline on general principles for model-informed drug development - Scientific guideline-2026/2/11
2026-02-12查看详情 > -
Document: ICH M15 Guideline on general principles for model-informed drug development - Step 5-2026/2/11
2026-02-12查看详情 > -
Page: Aliskiren product-specific bioequivalence guidance-2026/2/10
2026-02-11查看详情 > -
Document: PhV non-compliance notification contact points at National Competent Authority (NCA) level-2026/2/10
2026-02-11查看详情 > -
Document: Agenda of the CVMP meeting 10-12 February 2026-2026/2/10
2026-02-11查看详情 > -
Document: Annex to 16-19 June 2025 CHMP Minutes-2026/2/10
2026-02-11查看详情 > -
Document: Minutes of the CHMP meeting 16-19 June 2025-2026/2/10
2026-02-11查看详情 > -
Document: Article 57 product data-2026/2/10
2026-02-11查看详情 > -
Document: List of eligible industry stakeholder organisations-2026/2/10
2026-02-11查看详情 > -
Document: Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)-2026/2/10
2026-02-11查看详情 >
